biowaiver for Sim­va­statin sus­pension [Dissolution / BCS / IVIVC]

posted by Dr_Dan  – Germany, 2015-05-18 11:58 (3555 d 08:06 ago) – Posting: # 14847
Views: 6,866

Dear PJS
Applying for a BCS-based biowaiver is restricted to highly soluble drug substances with known human absorption (BCS class I&III). As you already stated above simvastatin is no highly soluble drug (BCS class II with a high intra-subject variability). Only if an active substance is considered highly soluble, it is reasonable to expect that it will not cause any bioavailability problems. In case of simvastatin you will not be able to determine the formulation effect unless you have performed a BE study.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,662 registered users;
254 visitors (0 registered, 254 guests [including 8 identified bots]).
Forum time: 19:05 CET (Europe/Vienna)

There are sadistic scientists who hurry to hunt down errors
instead of establishing the truth.    Marie Curie

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5